In a new study, researchers have developed an AI-powered neural network capable of identifying patients at risk of ...
The GLP-1 agonist has shown convincing benefits in yet another population, patients with peripheral arterial disease, in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback